​

Bolt Biotherapeutics Ownership | Who Owns Bolt Biotherapeutics?

OverviewForecastRevenueFinancialsChart

Bolt Biotherapeutics Ownership Summary

Bolt Biotherapeutics is owned by 47.80% institutional investors, 2.26% insiders, and 49.94% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.22% of BOLT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.51% of its assets in Bolt Biotherapeutics shares.

BOLT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBolt Biotherapeutics47.80%2.26%49.94%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Citadel advisors2.37M6.22%$1.78M
Blackrock267.07K0.70%$200.30K
Fmr129.25K0.34%$69.16K
Morgan stanley33.69K0.09%$25.27K
Tower research capital llc (trc)4.01K0.01%$2.14K
Bank of america corp /de/628.000.00%$471.00
Salem investment counselors---
Renaissance---
Susquehanna group, llp---
Engineers gate manager lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Citadel advisors2.37M0.00%$1.78M
Renaissance---
Tower research capital llc (trc)4.01K-$2.14K
Engineers gate manager lp---
Blackrock267.07K-$200.30K
Salem investment counselors---
Mariner---
Two sigma securities---
Susquehanna group, llp---
Prudential financial---

Top Buyers

HolderShares% AssetsChange
Fmr129.25K-13.87K
Blackrock267.07K-12.11K
Morgan stanley33.69K-9.00K
Tower research capital llc (trc)4.01K-3.82K
Bank of america corp /de/628.00--

Top Sellers

HolderShares% AssetsChange
Tang capital management---3.81M
Vivo capital---3.52M
Sofinnova investments---2.75M
Pivotal bioventure partners investment advisor---1.89M
Orbimed advisors---1.54M

Sold Out

HolderChange
Bnp paribas arbitrage, snc-1.00
Qube research-2.00
Salem investment counselors-40.00
Wells fargo & company/mn-211.00
Jpmorgan chase-906.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202528-24.32%18,325,858-1.84%472.01%10-41.18%5-
Dec 31, 20243719.35%18,670,034-0.60%482.02%1770.00%5-37.50%
Sep 30, 202431-11.43%18,782,187-16.99%491.39%10-37.50%833.33%
Jun 30, 202435-5.41%22,625,732-5.73%591.48%1660.00%6-45.45%
Mar 31, 202437-2.63%24,001,384-0.52%631.56%10-33.33%11-8.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv48.21K2.51%-
Vanguard US Total Market Shares ETF861.87K2.25%-1.00
Vanguard Institutional Extnd Mkt Idx Tr10.28K0.54%-1.00
Fidelity Extended Market Index7.05K0.37%-
Fidelity Total Market Index5.38K0.28%-
Fidelity Enhanced Small Cap ETF90.25K0.24%1.69K
Bridgeway Ultra-Small Company Market60.20K0.16%-
Spartan Extended Market Index Pool F3.01K0.16%-1.00
Spartan Extended Market Index Pool E58.62K0.15%1.23K
PGIM Quantitative Solutions US Micro Cap2.38K0.12%2.38K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 06, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.59K
Dec 16, 2024Nemec Sarah Senior VP, Finance and PAOBuy$1.24K
Jun 06, 2024Quinn William P. President, CEO and CFOBuy$1.59K
Dec 16, 2024Quinn William P. President, CEO and CFOBuy$1.24K
Jun 06, 2023Quinn William P. Chief Financial OfficerBuy$2.16K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4224
2023 Q21-

BOLT Ownership FAQ

Who Owns Bolt Biotherapeutics?

Bolt Biotherapeutics shareholders are primarily institutional investors at 47.80%, followed by 2.26% insiders and 49.94% retail investors. The average institutional ownership in Bolt Biotherapeutics's industry, Biotech Stocks , is 64.05%, which Bolt Biotherapeutics falls below.

Who owns the most shares of Bolt Biotherapeutics?

Bolt Biotherapeutics’s largest shareholders are Citadel advisors (2.37M shares, 6.22%), Blackrock (267.07K shares, 0.70%), and Fmr (129.25K shares, 0.34%). Together, they hold 7.26% of Bolt Biotherapeutics’s total shares outstanding.

Does Blackrock own Bolt Biotherapeutics?

Yes, BlackRock owns 0.70% of Bolt Biotherapeutics, totaling 267.07K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 200.3K$. In the last quarter, BlackRock increased its holdings by 12.11K shares, a 4.75% change.

Who is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Citadel advisors is Bolt Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 2.37M Bolt Biotherapeutics shares, valued at 1.78M$.

Who is the top mutual fund holder of Bolt Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bolt Biotherapeutics shares, with 2.51% of its total shares outstanding invested in 48.21K Bolt Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools